Disappointing results for clazosentan in CONSCIOUS-2

Clazosentan, an endothelin receptor antagonist, in patients with aneurysmal subarachnoid haemorrhage undergoing surgical clipping: a randomised, double-blind, placebo-controlled phase 3 trial (CONSCIOUS-2)

(2011) R Loch Macdonald et al.   LANCET NEUROLOGY

Quantitative Analysis of Hemorrhage Volume for Predicting Delayed Cerebral Ischemia After Subarachnoid Hemorrhage

(2011) Sang-Bae Ko et al.   STROKE

Angiographic Vasospasm Is Strongly Correlated With Cerebral Infarction After Subarachnoid Hemorrhage

(2011) R. Webster Crowley et al.   STROKE

Dissociation of Vasospasm and Secondary Effects of Experimental Subarachnoid Hemorrhage by Clazosentan

(2011) Mohammed Sabri et al.   STROKE

Spreading Depolarization

(2010) Lewis Z. Leng et al.   ARCHIVES OF NEUROLOGY

Time trends in outcome of subarachnoid hemorrhage: Population-based study and systematic review

(2010) C. E. Lovelock et al.   NEUROLOGY

Clazosentan: an endothelin receptor antagonist for treatment of vasospasm after subarachnoid hemorrhage

(2008) R Loch Macdonald   EXPERT OPINION ON INVESTIGATIONAL DRUGS

Microthrombosis after Aneurysmal Subarachnoid Hemorrhage: An Additional Explanation for Delayed Cerebral Ischemia

(2008) Mervyn DI Vergouwen et al.   JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM